Drug Trial Radar · NCT07010263
A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Last checked: Nov 19, 2026Latest source record: Mar 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
560
Planned (sponsor's estimate)
Start
Jun 13, 2025
Primary completion
Dec 31, 2028
Study completion Jul 31, 2029
Sponsor
- Lead sponsor
- AkesoIndustry
- Sponsor type
- Industry
- First posted
- Jun 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, phase III clinical study to compare the efficacy and safety of AK112 to placebo as consolidation treatment for patients with limited stage small cell lung cancer who have not progressed following concurrent chemoradiation therapy.
Conditions
- Small Cell Lung Cancer
Interventions
AK112Drug
AK112 20mg/kg, intravenous \[IV\]),Q3W
PlaceboOther
Placebo, intravenous \[IV\]),Q3W
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-Free Survival(PFS) assessed by Blinded independent center review(BIRC)Time frame: Approximately 6 years
- Overall Survival (OS)Time frame: Approximately 6 years
Locations
53 sites in 1 country. Site status is shown where the registry gives one.
Cancer Hospital, Chinese Academy of Medical Sciences
Beijin, Beijin, China · Recruiting
Beijing Cancer Hospital
Beijing, Beijing Municipality, China · Recruiting
The First Medical Center of Chinese PLA General Hospital
Beijing, Beijing Municipality, China · Recruiting
Beijing Chest Hospital
Beijing, Beijing Municipality, China · Recruiting
Beijing Luhe Hospital, Capital Medical University
Beijing, Beijing Municipality, China · Recruiting
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China · Recruiting
Fujian Cancer Hospital
Fuzhou, Fujian, China · Recruiting
PLA No. 900 Hospital of the Joint Support Force
Fuzhou, Fujian, China · Recruiting
Longyan First Hospital
Longyan, Fujian, China · Recruiting
Zhangzhou Municipal Hospital of Fujian Province
Zhangzhou, Fujian, China · Recruiting
Gansu Provincial Cancer Hospital
Lanzhou, Gansu, China · Recruiting
Jiangmen Central Hospital
Jiangmen, Guangdong, China · Recruiting
Liuzhou People's Hospital
Liuzhou, Guangxi, China · Recruiting
Affiliated Cancer Hospital of Guangxi Medical University
Nanning, Guangxi, China · Recruiting
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China · Recruiting
Guangdong Provincial People's Hospital
Guangzhou, Guangzhou, China · Recruiting
Guizhou Provincial People's Hospital
Guiyang, Guizhou, China · Recruiting
The Second Affiliated Hospital of Zunyi Medical University
Zunyi, Guizhou, China · Recruiting
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China · Recruiting
Tangshan People's Hospital
Tangshan, Hebei, China · Recruiting
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China · Recruiting
The Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China · Recruiting
Anyang Cancer Hospital
Anyang, Henan, China · Recruiting
The First Affiliated Hospital of Xinxiang Medical University
Xinxiang, Henan, China · Recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Recruiting
Jingzhou First People's Hospital
Jingzhou, Hubei, China · Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China · Not yet recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Recruiting
The First Affiliated Hospital of South China University
Hengyang, Hunan, China · Recruiting
General Hospital of the PLA Eastern Theater Command
Nanjing, Jiangsu, China · Recruiting
Jiangsu Cancer Hospital
Nanjing, Jiangsu, China · Recruiting
Xuzhou Municipal Hospital
Xuzhou, Jiangsu, China · Recruiting
The First Affiliated Hospital of Gannan Medical University
Gannan, Jiangxi, China · Recruiting
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China · Recruiting
Jilin Cancer Hospital
Changchun, Jilin, China · Recruiting
The First Hospital of China Medical University
Shenyang, Liaoning, China · Recruiting
Ningxia Medical University General Hospital
Yinchuan, Ningxia, China · Recruiting
Shandong Provincial Hospital
Jinan, Shandong, China · Recruiting
Shandong Cancer Hospital
Jinan, Shandong, China · Recruiting
Showing 40 of 53 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.